Completed PHASE2 INTERVENTIONAL 2-arm NCT00329758

Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head Injury

Phase II Study of Rosuvastatin´s Effect on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Humans With Moderate Head Injury

Sponsor: AstraZeneca

Conditions Head Injury

Interventions Placebo rosuvastatin

Updated 6 times since 2017 Last updated: Jun 23, 2010 Started: Jul 31, 2006 Primary completion: Oct 31, 2007 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Head Injury, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Hospital Central Dr. Ignacio Morones Prieto
Universidad Autonoma de San Luis Potosí

Data source: Universidad Autonoma de San Luis Potosí

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Luis Potosí City, Mexico